This announcement is a separate document:
荣昌生物2024年度向特定对象发行A股股票募集资金使用的可行性分析报告
Feasibility analysis report on the use of funds raised by Rongchang Biotech by issuing A-shares to specific targets in 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.